We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Shanghai Fosun Pharmaceutical Group, or Fosun Pharma, said research-and-development unit Shanghai Henlius Biotech will raise $190 million from a new share issue.